Immunization Clinical Trials

61 clinical trials for Immunization across international registries, including 16 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Influenza Immunization in Adults Over Age 75 — RECRUITING · NA
• Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old) — RECRUITING · PHASE4
• Description of the Immune Response to Yellow Fever Vaccination — RECRUITING · NA
• Adjuvant Effect of Physical Exercise on Immune Response to COVID-19 Vaccination and Interactions With Stress — RECRUITING · NA
• A PHASE 3 DOUBLE-BLIND RANDOMIZED CONTROLLED TRIAL TO COMPARE THE IMMUNOGENICITY AND SAFETY OF A THREE-DOSE REGIMEN OF SCI-B-VAC TO A THREE-DOSE REGIMEN OF ENGERIX-B IN ADULTS — RECRUITING · PHASE3
• A DOUBLE-BLIND RANDOMIZED CONTROLLED TRIAL TO ASSESS THE LOT-TO-LOT CONSISTENCY OF SCI-B-VAC IN ADULTS — RECRUITING
• A PHASE 3, PLACEBO-CONTROLLED, RANDOMIZED, OBSERVER-BLINDED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER — RECRUITING · PHASE3
• VACCINATING CHILDREN AFTER CHEMOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKEMIA — RECRUITING
• A PHASE IV, OPEN-LABEL, NON-RANDOMISED, MULTICENTRE STUDY TO ASSESS THE LONG-TERM PERSISTENCE OF IMMUNITY TO HEPATITIS B IN ADULTS VACCINATED 20 TO 30 YEARS AGO WITH 3 OR 4 DOSES OF GSK BIOLOGICALS' HEPATITIS B VACCINE, ENGERIX-B — RECRUITING · PHASE4
• A PHASE IV, OPEN-LABEL, NON-RANDOMISED, MULTI-CENTRE STUDY TO ASSESS THE IMMUNOGENICITY AND SAFETY OF A BOOSTER DOSE OF INFANRIX HEXA IN HEALTHY INFANTS BORN TO MOTHERS VACCINATED WITH BOOSTRIX DURING PREGNANCY OR IMMEDIATELY POST-DELIVERY — RECRUITING · PHASE4
• A PHASE III, RANDOMIZED, PLACEBO-CONTROLLED, CLINICAL TRIAL TO STUDY THE SAFETY AND IMMUNOGENICITY OF THREE CONSISTENCY LOTS AND A HIGH DOSE LOT OF RVSV-ZEBOV-GP (V920 EBOLA VACCINE) IN HEALTHY ADULTS — RECRUITING · PHASE3
• A PHASE 3B, OPEN LABEL, CONTROLLED, MULTI CENTER, EXTENSION STUDY TO ASSESS THE PERSISTENCE OF BACTERICIDAL ACTIVITY AT 4 TO 7.5 YEARS AFTER TWO DOSE PRIMARY SERIES OF NOVARTIS MENINGOCOCCAL B RECOMBINANT VACCINE AND THE RESPONSE TO A THIRD DOSE IN ADOLESCENTS AND YOUNG ADULT SUBJECTS WHO PREVIOUSLY PARTICIPATED IN PARENT STUDIES V72_41 AND V72PI0, COMPARED TO NAIVE HEALTHY CONTROLS — RECRUITING · PHASE3
• A RANDOMIZED, OBSERVER-BLIND, MULTICENTER, PHASE 2B STUDY TO ASSESS THE IMMUNOGENICITY, SAFETY, AND TOLERABILITY OF A PLANT-DERIVED QUADRIVALENT VLP INFLUENZA VACCINE IN ELDERLY ADULTS OF 65 YEARS OF AGE OR OLDER — RECRUITING · PHASE2
• A RANDOMIZED, OBSERVER-BLIND, MULTICENTER, PHASE 2B STUDY TO ASSESS THE IMMUNOGENICITY, SAFETY, AND TOLERABILITY OF A PLANT-DERIVED QUADRIVALENT VLP INFLUENZA VACCINE IN ADULTS 18-64 YEARS OF AGE — RECRUITING · PHASE2
• A PHASE IV, OBSERVER-BLIND, RANDOMISED, CROSS-OVER, PLACEBO-CONTROLLED, MULTICENTRE STUDY TO ASSESS THE IMMUNOGENICITY AND SAFETY OF A SINGLE DOSE OF BOOSTRIX IN PREGNANT WOMEN. — RECRUITING · PHASE4
• A PHASE IV, OPEN-LABEL, NON-RANDOMISED, MULTI-CENTRE STUDY TO ASSESS THE IMMUNOGENICITY AND SAFETY OF INFANRIX HEXA ADMINISTERED AS PRIMARY VACCINATION IN HEALTHY INFANTS BORN TO MOTHERS GIVEN BOOSTRIX DURING PREGNANCY OR POST-DELIVERY IN 116945 [DTPA(BOOSTRIX)-047]. — RECRUITING · PHASE4
• Pediatric Vaccinations — COMPLETED
• GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose — COMPLETED · PHASE4
• Safety and Efficacy of BK1310 Intramuscular Injection in Healthy Infants — COMPLETED · PHASE3
• Post-marketing Surveillance Study for the Safety of Efluelda Tetra Pre-filled Syringe. — NOT_YET_RECRUITING
• The Dreamy Jet Study — WITHDRAWN · PHASE1
• mHealth-Assisted Conditional Cash Transfers to Improve Timeliness of Vaccinations (D0271) — COMPLETED · NA
• The STOP-HPV Trial 1: Communication Intervention — COMPLETED · NA
• HPV Vaccination Study in Postpartum Women — COMPLETED · PHASE4
• Comparing the Use of a Mobile App for Surveillance of Adverse Events Following Influenza Immunization to a Web-Based Platform — COMPLETED · NA
• The STOP-HPV Trial 6: Single Arm Evaluation of the Maintenance of the STOP-HPV Bundle — WITHDRAWN · NA
• The STOP-HPV Trial 5: Single Arm Evaluation of the Bundle — OTHER · NA
• FluPRINT Study: Characterisation of the Immune and Transcriptional Response to LAIV — COMPLETED · NA
• The STOP-HPV Trial 3: Prompts Intervention — OTHER · NA
• The STOP-HPV Trial 4: Bundle Intervention — OTHER · NA
• State Immunization Information Systems to Improve HPV Vaccination Rates — COMPLETED · NA
• The STOP-HPV Trial 2: Performance Feedback Intervention — COMPLETED · NA
• Effect of Infant Immunization on Procalcitonin Levels - A Pilot Study — COMPLETED
• Assessing Barriers and Increasing Use of Immunization Registries in Pharmacies — COMPLETED · NA
• Assessment of Novel Pneumococcal Conjugate Vaccination Scheduled in UK Infants — WITHDRAWN · PHASE4
• Pertussis and Meningitis C Concomitant Vaccination in Adolescents — COMPLETED · PHASE4
• Immunization Schedule Alert Platform — OTHER · NA
• PRIMM Trial (Phone Reminder for IMMunization) — COMPLETED · NA
• Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Preterm Compared to Term Infants. — COMPLETED · PHASE4
• Immunization Services Model for Adult Rate Improvement — COMPLETED · NA
• Study of Adolescent Immunization Recall Systems — COMPLETED · NA
• A PHASE II, DOUBLE-BLIND, RANDOMIZED, MULTICENTER TRIAL TO EVALUATE THE SAFETY,TOLERABILITY, AND IMMUNOGENICITY OF V114 COMPARED TO PREVNAR 13TM IN HEALTHY INFANTS — COMPLETED · PHASE2
• A PHASE I/II, RANDOMISED, OBSERVER-BLIND, CONTROLLED MULTI-COUNTRY STUDY TO ASSESS THE SAFETY, REACTOGENICITY AND IMMUNOGENICITY OF A SINGLE INTRAMUSCULAR DOSE OF GSK BIOLOGICALS' INVESTIGATIONAL RSV VACCINE (GSK3003891A), IN HEALTHY PREGNANT WOMEN AGED 18 TO 40 YEARS AND INFANTS BORN TO VACCINATED MOTHERS — NOT_YET_RECRUITING · PHASE1
• Trial to Reduce Alloimmunization to Platelets (TRAP) — COMPLETED · PHASE3
• A RANDOMIZED CONTROLLED TRIAL OF ADJUVANTED VACCINE VERSUS INACTIVATED INFLUENZA VACCINE IN HUTTERITE CHILDREN — NOT_YET_RECRUITING
• A PHASE 2 RANDOMIZED, MULTI-CENTER DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF THE V920 (RVSVG-ZEBOV-GP) EBOLA VIRUS VACCINE CANDIDATE IN HIV-INFECTED ADULTS AND ADOLESCENTS — NOT_YET_RECRUITING · PHASE2
• A MULTICENTER STUDY OF THE IMMUNOGENICITY OF RECOMBINANT VESICULAR STOMATITIS VACCINE FOR EBOLA-ZAIRE (RVSVAG-ZEBOV-GP) FOR PRE-EXPOSURE PROPHYLAXIS (PREP) IN INDIVIDUALS AT POTENTIAL OCCUPATIONAL RISK FOR EBOLA VIRUS EXPOSURE — NOT_YET_RECRUITING
• LONG TERM IMMUNE MEMORY RESPONSES TO HUMAN PAPILLOMAVIRUS (HPV) VACCINATION FOLLOWING 2 VERSUS 3 DOSES OF QUADRIVALENT HPV VACCINE — NOT_YET_RECRUITING
• PREPAREDNESS FOR AND RESPONSE TO MENINGOCOCCAL OUTBREAKS: A PILOT STUDY OF THE IMMUNOGENICITY, REACTOGENICITY AND TOLERABILITY OF TWO SCHEDULES OF A 4CMENB VACCINE IN ADOLESCENTS AND YOUNG ADULTS — NOT_YET_RECRUITING
• Music Therapy as Procedural Support for Young Children Undergoing Immunizations — COMPLETED · NA

Refine this search